Subclone 11 contained EIF4G3, IL12RB2, and PDE4B mutations, and all three mutations had zero allele frequencies in the tumor sample P6_T11, indicating the possibility of secondary driver genes for this subclone. This evidence concerns the gene IL12RB2 and neoplasm.